Table 5.

Clinical appearance of cutaneous diphtheria and complications according to toxigenic status.

Clinic	Toxinogen						p
	No N = 34			Yes N = 22
	n	(%)	[CI95%]	n	(p)	[CI95%]
Ulcerated lesion	28	(62.2)	[46.9-77.5]	17	(37.8)	[22.5-53.1]	0.498
Erythemato purpulish ulceration border	18	(69.2)	[49.6-88.9]	8	(30.8)	[11.1-50.4]	0.343
Raised border	6	(50.0)	[17.5-82.5]	6	(50.0)	[17.5-82.5]	0.483
Indurated border	5	(45.5)	[11.5-79.4]	6	(54.5)	[20.6-88.5]	0.281
Pseudomembrane	2	(100.0)	[75.0-100.0]	0	(0.0)	[0.0-25.0]	0.509
Nodular lesion	2	(40.0)	[0.0-92.9]	3	(60.0)	[7.1-100.0]	1.000
Papular lesion	4	(50.0)	[9.1-90.9]	4	(50.0)	[9.1-90.9]	0.700
Necrotic lesion	6	(75.0)	[38.7-100.0]	2	(25.0)	[0.0-61.3]	0.449
Vesicular lesion	3	(60.0)	[7.1-100.0]	2	(40.0)	[0.0-92.9]	1.000
Pustular lesion	4	(44.4)	[6.4-82.5]	5	(55.6)	[17.5-93.6]	0.457
Crusty lesion	10	(55.6)	[29.8-81.3]	8	(44.4)	[18.7-70.2]	0.769
Painful lesion	19	(67.9)	[48.8-86.9]	9	(32.1)	[13.1-51.2]	0.171
Pruritic lesion	2	(25.0)	[0.0-61.3]	6	(75.0)	[38.7-100.0]	0.052
Edema	10	(58.8)	[32.5-85.2]	7	(41.2)	[14.8-67.5]	1.000
Peripheral desquamation	6	(54.5)	[20.6-88.5]	5	(45.5)	[11.5-79.4]	0.744
Number of lesions							0.532
1	16	(69.6)	[48.6-90.5]	7	(30.4)	[9.5-51.4]
2–5	11	(52.4)	[28.6-76.1]	10	(47.6)	[23.9-71.4]
>5	7	(58.3)	[26.3-90.4]	5	(41.7)	[9.6-73.7]
Size of lesions							0.374
<1 cm	7	(53.8)	[22.9-84.8]	6	(46.2)	[15.2-77.1]
1–5 cm	15	(60.0)	[38.8-81.2]	10	(40.0)	[18.8-61.2]
>5 cm	11	(78.6)	[53.5-100.0]	3	(21.4)	[0.0-46.5]
Complications
Arthritis	4	(100.0)	[87.5-100.0]	0	(0.0)	[0.0-12.5]	0.539
Bacteraemia	3	(100.0)	[83.3-100.0]	0	(0.0)	[0.0-16.7]	0.246
Peripheral neuropathy	0	(0.0)	[0.0-16.7]	3	(100.0)	[83.3-100.0]	0.010
Respiratory distress	1	(100.0)	[50.0-100.0]	0	(0.0)	[0.0-50.0]	1.000